Published in J Neurosci on November 26, 2003
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22
Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci (2014) 2.18
The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc Natl Acad Sci U S A (2005) 1.71
Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A (2006) 1.64
The function of activity-regulated genes in the nervous system. Physiol Rev (2009) 1.54
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc Natl Acad Sci U S A (2012) 1.53
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Dietary factors, hormesis and health. Ageing Res Rev (2007) 1.50
Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat (2009) 1.48
Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A (2008) 1.46
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Nuclear calcium signalling in the regulation of brain function. Nat Rev Neurosci (2013) 1.44
Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology (2008) 1.42
Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity. J Neurosci (2008) 1.41
VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol (2007) 1.41
The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci (2007) 1.34
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J Neurosci (2005) 1.30
Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience (2007) 1.23
Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology (2009) 1.21
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol (2012) 1.19
Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci U S A (2012) 1.16
Neurotransmitters couple brain activity to subventricular zone neurogenesis. Eur J Neurosci (2011) 1.14
The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci (2008) 1.13
Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis (2011) 1.13
Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci (2007) 1.12
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl) (2011) 1.12
Regulation of postsynaptic RapGAP SPAR by Polo-like kinase 2 and the SCFbeta-TRCP ubiquitin ligase in hippocampal neurons. J Biol Chem (2008) 1.10
Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes. Brain Res (2008) 1.09
Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol Psychiatry (2010) 1.07
Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress. J Neurosci (2009) 1.07
A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry (2008) 1.06
Stress coping stimulates hippocampal neurogenesis in adult monkeys. Proc Natl Acad Sci U S A (2010) 1.05
Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders. Neural Plast (2012) 1.03
Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning. Neuroscience (2007) 1.01
CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure. Biol Psychiatry (2007) 1.01
Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res (2011) 1.01
Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res (2008) 1.00
Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proc Natl Acad Sci U S A (2012) 0.99
Neuropeptides in depression: role of VGF. Behav Brain Res (2008) 0.97
Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural Plast (2013) 0.96
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology (2010) 0.94
Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease. Front Neuroendocrinol (2013) 0.93
The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology (2010) 0.93
A molecular characterization of the choroid plexus and stress-induced gene regulation. Transl Psychiatry (2012) 0.93
Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci (2012) 0.93
Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol (2008) 0.92
Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast (2014) 0.91
17β-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus. Endocrinology (2011) 0.91
Recruitment of the Sonic hedgehog signalling cascade in electroconvulsive seizure-mediated regulation of adult rat hippocampal neurogenesis. Eur J Neurosci (2005) 0.90
Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades. Drug Discov Today Ther Strateg (2008) 0.90
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull (2011) 0.89
Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature. PLoS One (2015) 0.87
Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86
Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res Bull (2007) 0.85
fosB-null mice display impaired adult hippocampal neurogenesis and spontaneous epilepsy with depressive behavior. Neuropsychopharmacology (2012) 0.84
Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biol Psychiatry (2011) 0.84
Immunohistochemical evaluation of the protein expression of nerve growth factor and its TrkA receptor in rat limbic regions following electroshock seizures. Neurosci Res (2009) 0.84
Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm (Vienna) (2009) 0.83
Antipsychotic-induced gene regulation in multiple brain regions. J Neurochem (2010) 0.83
Decreased plasma brain-derived neurotrophic factor and vascular endothelial growth factor concentrations during military training. PLoS One (2014) 0.83
Pathogenesis of depression: Insights from human and rodent studies. Neuroscience (2015) 0.82
Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialogues Clin Neurosci (2004) 0.82
Genome-wide gene expression profiling in GluR1 knockout mice: key role of the calcium signaling pathway in glutamatergically mediated hippocampal transmission. Eur J Neurosci (2009) 0.82
Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis. PLoS One (2013) 0.82
Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. Ther Adv Psychopharmacol (2012) 0.81
Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition. Epilepsia (2011) 0.81
Molecular profiling of the lateral habenula in a rat model of depression. PLoS One (2013) 0.81
Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. J Neural Transm (Vienna) (2008) 0.81
The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction. Brain Res (2015) 0.81
Mammalian target of rapamycin complex 1 activation negatively regulates Polo-like kinase 2-mediated homeostatic compensation following neonatal seizures. Proc Natl Acad Sci U S A (2013) 0.81
Tamalin is a critical mediator of electroconvulsive shock-induced adult neuroplasticity. J Neurosci (2012) 0.81
Association study of early-immediate genes in childhood-onset mood disorders and suicide attempt. Psychiatry Res (2012) 0.80
Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1. Hum Mol Genet (2014) 0.80
Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? Transl Psychiatry (2015) 0.79
VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures. PLoS One (2012) 0.79
Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex. Exp Mol Med (2008) 0.78
Use of stem cell transplantation to treat epilepsy: A Web of Science-based literature analysis. Neural Regen Res (2012) 0.77
A marked effect of electroconvulsive stimulation on behavioral aberration of mice with neuron-specific mitochondrial DNA defects. PLoS One (2008) 0.76
Indomethacin induced gene regulation in the rat hippocampus. Mol Brain (2015) 0.76
Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms. Int J Mol Sci (2017) 0.75
Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. Neural Plast (2016) 0.75
Acute and Chronic Electroconvulsive Seizures (ECS) Differentially Regulate the Expression of Epigenetic Machinery in the Adult Rat Hippocampus. Int J Neuropsychopharmacol (2016) 0.75
Extracellular proteolysis in structural and functional plasticity of mossy fiber synapses in hippocampus. Front Cell Neurosci (2015) 0.75
Transcriptome sequencing of the choroid plexus in schizophrenia. Transl Psychiatry (2016) 0.75
Neuromodulation for mood and memory: from the engineering bench to the patient bedside. Curr Opin Neurobiol (2014) 0.75
Microarray Analysis of Human Blood During Electroconvulsive Therapy. J ECT (2015) 0.75
Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.75
How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms. Clin Psychopharmacol Neurosci (2017) 0.75
BDNF at the synapse: why location matters. Mol Psychiatry (2017) 0.75
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (2010) 10.97
The many faces of CREB. Trends Neurosci (2005) 5.58
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci (2002) 5.17
Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology (2007) 4.38
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci Transl Med (2012) 3.99
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry (2011) 3.62
A negative regulator of MAP kinase causes depressive behavior. Nat Med (2010) 3.52
American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr (2011) 3.32
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol (2007) 3.32
BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol (2012) 3.24
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med (2008) 3.15
The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med (2011) 3.14
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med (2012) 3.14
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus (2006) 3.02
Preclinical models: status of basic research in depression. Biol Psychiatry (2002) 2.76
Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology (2003) 2.75
Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov (2010) 2.68
Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron (2003) 2.41
Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci (2004) 2.27
Retracted A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak Syndrome type 9. Am J Hum Genet (2011) 2.25
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci (2002) 2.21
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A (2010) 2.17
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest (2006) 2.14
Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry (2008) 2.14
Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH. Neurology (2014) 2.08
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry (2007) 2.01
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med (2012) 1.97
Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem (2004) 1.96
A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry (2006) 1.95
Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry (2007) 1.94
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest (2007) 1.91
Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci (2002) 1.89
Detecting false-positive signals in exome sequencing. Hum Mutat (2012) 1.87
Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron (2003) 1.84
Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res (2008) 1.84
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology (2010) 1.81
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry (2004) 1.77
Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry (2011) 1.77
Antidepressant actions of the exercise-regulated gene VGF. Nat Med (2007) 1.69
TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry (2006) 1.67
Antidepressants and neuroplasticity. Bipolar Disord (2002) 1.66
American Society of Echocardiography: Remote Echocardiography with Web-Based Assessments for Referrals at a Distance (ASE-REWARD) Study. J Am Soc Echocardiogr (2013) 1.62
Estimating sympathetic tone by recording subcutaneous nerve activity in ambulatory dogs. J Cardiovasc Electrophysiol (2014) 1.61
Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci (2002) 1.58
Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet (2011) 1.54
Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology (2003) 1.53
Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets (2007) 1.47
Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol (2007) 1.47
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A (2008) 1.46
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology (2013) 1.44
Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry (2013) 1.44
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A (2005) 1.44
Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol (2009) 1.43
The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun (2012) 1.42
VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol (2007) 1.41
Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology (2006) 1.40
Vasculitis neuropathy mimicking lower limb mono-radiculopathy: a study and follow-up of 8 cases. Intern Emerg Med (2012) 1.40
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med (2014) 1.39
GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology (2013) 1.37
Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci (2009) 1.36
Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci (2004) 1.34
Patient concerns about medical errors in emergency departments. Acad Emerg Med (2005) 1.32
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30
mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. Int J Neuropsychopharmacol (2011) 1.28
Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry (2013) 1.26
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med (2012) 1.26
Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem (2006) 1.26
Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry (2004) 1.25
Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology (2009) 1.21
Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology (2012) 1.21
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol (2012) 1.19
A double dissociation revealing bidirectional competition between striatum and hippocampus during learning. Proc Natl Acad Sci U S A (2008) 1.19
Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci (2005) 1.17
Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.16
Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol Psychiatry (2008) 1.16
Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol Psychiatry (2012) 1.14
Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacology (2005) 1.14
Isolated right segmental hepatic duct injury following laparoscopic cholecystectomy. Cardiovasc Intervent Radiol (2005) 1.13
Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. Eur J Neurosci (2008) 1.11
Etifoxine improves peripheral nerve regeneration and functional recovery. Proc Natl Acad Sci U S A (2008) 1.10
Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry (2003) 1.09
A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during endocytosis. Nat Cell Biol (2013) 1.08
VAR-MD: a tool to analyze whole exome-genome variants in small human pedigrees with mendelian inheritance. Hum Mutat (2012) 1.08
Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol Psychiatry (2010) 1.07
Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis (2012) 1.07
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett (2009) 1.07
A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry (2008) 1.06
Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) 1.05
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood (2002) 1.05
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs (2009) 1.05
Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane. Proc Natl Acad Sci U S A (2012) 1.04
Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol (2002) 1.04